2929 N COMMERCE PKWY, MIRAMAR, FL
Other Events
Regained Compliance with Bid Price Rule
Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
Stockholders Elect Class II Directors at HCW Biologics Annual Meeting
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules
Q1
FY 2025
Q3
Q2
Notice of Late Filing for Quarterly Report
FY 2024
Amended Registration Statement for Securities
Effectiveness Notice
S-1
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(4)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload